Thyroid as a target of adjuvant autoimmunity/inflammatory syndrome due to mRNA-based SARS-CoV2 vaccination: from Graves’ disease to silent thyroiditis

BACKGROUND: As COVID-19 became a pandemic, the urgent need to find an effective treatment vaccine has been a major objective. Vaccines contain adjuvants which are not exempt from adverse effects and can trigger the autoimmune/inflammatory syndrome induced by adjuvants (ASIA). There is very little in...

Descripción completa

Detalles Bibliográficos
Autores principales: Pujol, A., Gómez, L.-A., Gallegos, C., Nicolau, J., Sanchís, P., González-Freire, M., López-González, Á. A., Dotres, K., Masmiquel, L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2021
Materias:
Rapid Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8598936/
https://www.ncbi.nlm.nih.gov/pubmed/34792795
http://dx.doi.org/10.1007/s40618-021-01707-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8598936/
https://www.ncbi.nlm.nih.gov/pubmed/34792795
http://dx.doi.org/10.1007/s40618-021-01707-0

Ejemplares similares